key: cord-0980807-p1xc67ke
authors: Serafim, Rodrigo B.; Póvoa, Pedro; Souza-Dantas, Vicente; Kalil, André C.; Salluh, Jorge I.F.
title: Clinical course and outcomes of critically-ill patients with COVID-19 infection: A systematic review
date: 2020-10-23
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2020.10.017
sha: 1cd6556d0fee20bed4af5d122151c2ea5a17786f
doc_id: 980807
cord_uid: p1xc67ke

BACKGROUND: COVID-19 is a major cause of hospital admission and represents a challenge for patient management during intensive care unit (ICU) stay. OBJECTIVES: We aimed to describe the clinical course and outcomes of COVID-19 pneumonia in critically ill patients. DATA SOURCE: We performed a systematic search of peer-reviewed publications in MEDLINE, EMBASE and Cochrane Library up to August 15(th), 2020. Preprints and reports were also included if they met the inclusion criteria. STUDY ELIGIBILITY CRITERIA: Full-text prospective, retrospective or registry-based publications describing outcomes in patients admitted to the ICU for COVID-19, using a validated test. PARTICIPANTS: Critically ill patients admitted in the ICU with COVID-19 infection. RESULTS: From 32 articles included, a total of 69,093 patients were admitted to the ICU and were evaluated. Most patients admitted to the ICU were male (76,165/128,168 (59%); 26 studies) and the mean patient age was 56 (95% CI 48.5 – 59.8) years-old. Studies described high ICU mortality (21,145/65,383; 32.3%; 15 studies). The median length of ICU stay was 9.0 (95% CI 6.5 – 11.2) days, described in 5 studies. More than half of patients admitted to the ICU required mechanical ventilation (31,213/53,465; 58%; 23 studies) and among them mortality was very high (27,972/47,632, 59%, 6 studies). The duration of mechanical ventilation was 8.4 (95% CI 1.6 – 13.7) days. The main interventions described were the use of non-invasive ventilation, extracorporeal membrane oxygenation, renal replacement therapy and vasopressors. CONCLUSION: This systematic review including approximately 69,000 ICU patients demonstrates that COVID-19 infection in critically ill patients is associated with high need for life-sustaining interventions, high mortality and prolonged length of ICU stay.

Since the first case of COVID-19, identified in December 2019, the disease has spread rapidly infecting millions of people worldwide and causing a major challenge for healthcare systems [1] . Although asymptomatic or mild disease occurs in most cases, a subset of patients develops moderate-to-severe COVID-19 pneumonia (or severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection) requiring intensive care unit (ICU) admission [2] [3] [4] . As an exceptionally high number of cases required hospitalization, emergency departments and ICUs were strained and, in several countries, ICUs were unable to deliver enough beds and ventilators for patients with respiratory distress [1, 5] .

However, despite the numerous reports of critically ill patients in the literature [2, 6] , the clinical course, outcomes and interventions of patients admitted to the ICU are unclear.

Owing to the differences in design, patient population, and geographies, there is a large variation in the ICU admission rate (4.0% [7] to 32% [8] ) and mortality rate (0.7% [9] to J o u r n a l P r e -p r o o f 52.4% [10] ) in patients with COVID-19 among studies. Moreover, as patients with COVID-19 often have severe presentations and multiorgan failure and require lifesustaining interventions for basic care (e.g. personal protective equipment and laboratory analysis), there is a need of highly skilled staff and more sophisticated and expensive interventions such as invasive mechanical ventilation, extracorporeal membrane oxygenation (ECMO), and renal replacement therapy (RRT) [2, 6] .

A more comprehensive knowledge of ICU utilization and outcomes could potentially help healthcare professionals and managers to estimate the need for ventilators, ICU beds, and dialysis monitors and to more adequately manage their staffing patterns.

These findings have significant implications for better understanding the epidemiology of COVID-19 and for a better planning and organization of hospitals and ICUs to ensure better preparation and optimize delivery of care under the pandemic circumstances.

In the present study we performed a systematic review of the current literature aiming to describe the clinical course, interventions used and short-term outcomes of COVID-19 pneumonia requiring ICU admission.

We conducted a systematic review of the literature according to the recommendations of the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group [11] and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [12] . We searched MEDLINE, EMBASE and the Cochrane Library. reports. All selections were decided by consensus. This report was prospectively registered with the PROSPERO database of systematic reviews (CRD42020180850).

Data extraction from the selected articles was independently performed by two authors (RBS, JIFS). The following data were recorded (when available): study characteristics (such as type of study, selection of patients, number of patients enrolled, publication date); patients' characteristics (such as age, sex, patients setting); and outcomes (ARDS incidence, need of MV, vasopressor used, death in the ICU and hospital, all patients ICU and hospital LOS). We considered the center has an ICU accordingly with the description of each author, data was not available to allow another classification as well as to allow further characterization. The ICNARC report described ICU and high dependence units together in the same analysis [6] .

To assess the methodological quality of the studies, we adapted the Newcastle -Ottawa Quality Assessment Scale (NOS) [13] to better describe the risk of bias in our systematic review (supplement table 1).

We evaluated COVID-19 patients' characteristics and main outcomes described.

We had especial interest in describing, mortality, LOS and the interventions used (MV, non-invasive ventilation (NIV), RRT and vasopressors use). For continuous variables, we described the mean and 95% confidence interval (CI) based on the reported data.

Proportions were described with the numerator/denominator and percentages. We used the SPSS v21 to analyze the data. Owing to the differences in design of the studies, we were not able to perform a meta-analysis.

The literature search yielded 2927 studies. Of the 320 potentially relevant abstracts screened, 74 articles were available for detailed analysis. Finally, 32 articles that met the inclusion criteria were included in this systematic review. A flow diagram of the search and selection of the studies is depicted in Figure 1 .

The characteristics of the 32 included studies are shown in Table 1 . Twenty-eight studies [3] [4] [5] [8] [9] [10] and five non-peer reviewed reports from national registries or research groups [2, 6, [36] [37] [38] were included. A total of 69,093 patients were admitted in the ICU and were evaluate. Most studies were performed in China, but they represent only 1.35% (932/69,093) of ICU patients described [3, 4, 9, [16] [17] [18] [19] [20] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [5, 8, 10, 14, 15, 18, 23, 29, 36] . Only one study described a 28-day mortality [31] and no studies described long term-outcomes after hospital discharge.

Studies reported different results regarding symptoms, time to critical illness, clinical course, development of organ failure, interventions used, and short-term outcomes. The NOS score of each study is show in supplement table 2.

The design, sample size, and outcomes in all the studies were highly variable. Figure 2 shows the number of patients included from each country. Most ICU patients were males (76,165/128,168 (59%); 26 studies) [2] [3] [4] [5] [6] 9, 10, 14, 15, 17, 18, [21] [22] [23] [24] [25] [26] [27] 29, [31] [32] [33] [34] 36] and the mean patient age was 56 (95% CI 48.5 -59.8; 11 studies) [5, 6, 10, 14, 15, 23, 27, 29, 34, 36, 37] years-old. Nine studies [3, [8] [9] [10] 18, 22, 26, 28, 31] described the diagnosis of ARDS in patients admitted to the ICU (316/365, 85%). Most patients with ARDS were male (240/316; 76.2%, 9 studies), and the median age was 53 (95% CI 48.2 -62.8) years old [3, [8] [9] [10] 18, 22, 26, 28, 31] .

Regarding short-term outcomes most studies described ICU mortality and LOS. Studies described a high ICU mortality (21,145/65,383; 32.3%; 15 studies) [2, 5, 6, 8, 10, 14, 15, 20, 23, 27, 31, 34, 35, 36] and the median ICU LOS was 9.0 (95% CI 6.5 -11.2) days [6, 2, 9, 25, 26, 28, 18, [34] [35] [36] [37] ( Table 2 ). The mortality in patients requiring invasive MV was described in six studies (27,972/47,632, 59%) [6, 21, 28, 31, 33, 36] . Only J o u r n a l P r e -p r o o f two studies described the mortality in patients with ARDS in the ICU that was 93% (50/59) [29] and 71% (26/35) [32] , respectively. Only three studies described the duration of MV, and the median was 8.4 (95% CI 1.6 -13.7) days [2, 6, 34] . The surge in patients with COVID-19 requiring hospitalization, ICU admission, and ventilatory support represented an unparalleled challenge to physicians, nurses, hospital managers and healthcare systems. However, despite the rapid response of the medical community, the burden of COVID-19 on ICU facilities is unclear. Despite a lack of studies, this systematic review was able to provide relevant data on ICU utilization from peer-reviewed articles [4, 5, [8] [9] [10] 14, [15] [16] [17] [18] [19] [20] [21] [22] [23] [25] [26] [27] [28] 29, [31] [32] [33] 34, 36, 38] , three non-peer-reviewed preprints [14, 27, 30] and also five large databases of scientific institutions and National registries of intensive care [2, 6, [35] [36] [37] . This review provides a unique international perspective on the interventions used and outcomes in patients with COVID-19 requiring ICU, thus increasing the current epidemiological knowledge and potentially providing useful information to help care for these patients.

Our study shows the high burden of COVID-19 on ICUs, which was demonstrated by the exceedingly high mortality and LOS even when compared to other infectious diseases requiring ICU admission. The ICU mortality rate among patients with COVID-19 was 30.6%, which is relevant even when compared to the usually described mortality rates of community-acquired pneumonia (CAP) of about 16.6%-18% [39] [40] and that was described in sepsis 24.2%-55.7% [41, 42] . Moreover, when considering only mechanically ventilated patients the mortality was exceptionally high (27,972/47,632, 59%, 6 studies) [6, 21, 28, 31, 33, 36] especially in ARDS patients (up to 93%) which is more than the typical mortality rate from ARDS of about 35%-45% [43, 44] . We also described an elevated ICU LOS for COVID-19 (8.0 [95% IC 5.1 -11.0]) as compared to J o u r n a l P r e -p r o o f described in patients with severe CAP [39, 45] representing a challenge in ICU bed management.

Our study described that almost half of patients admitted to the ICU need invasive MV (58%) and a lower percentage required non-invasive ventilation (25.5%). Studies in CAP described a much high proportion of patients (up to 56%) using NIV in acute respiratory failure [45, 46] . Indeed, the role of NIV in COVID-19 remains unclear. The uncertainty around the treatment of acute hypoxemic respiratory failure with NIV [47] plus the purported risks of aerosolization generation and delayed intubation have led to varying recommendations between authorities [7, 48] potentially contributing to a limited use.

The use of ECMO as a salvage therapy for critically ill COVID-19 patients was limited and described in a small number of patients (272/11494; 2.4%; 11 studies) [2, 3, 5, 8, 9, 16, 18, 22, 26, 28, 31] . Mortality in ECMO was described in only 3 studies and was very high (9/10; 90%) [3, 28, 31] . It remains unclear if ECMO therapy is associated with improved outcomes. A recent study using data from the Extracorporeal Life Support Organization (ELSO) included 1035 patients with COVID-19 who received ECMO and also described a high mortality (380/968; 39%) and a significant percentage of patients (101/1035; 10%) discharged to a long-term acute care centre [38] . Published studies from different countries describing the use of ECMO as rescue therapy in the 2009 H1N1 pandemic have reported lower mortality rates than that reported during the current COVID-19 pandemic (14%-41%) [49] [50] [51] [52] .

This study has several limitations. First, owing to the urgency of publishing preliminary information on patients with COVID-19 during the current pandemic, studies have J o u r n a l P r e -p r o o f presented very heterogeneous data on clinical characteristics, interventions used, and outcomes of ICU patients. Significant differences in the design of the studies also contributed to the lack of specific and core clinical information in several reports. This limited our ability to pool and meta-analyze data on specific subgroups. In supplement table 3, we have suggested a list of outcomes that should be assessed in future studies describing critically ill patients with COVID-19 [53, 54] . Second, the sample sizes varied significantly, ranging from 20 patients in small cohort studies up to 64,979 patients in reports from national ICU registries. Third, the classification of ICU patients was performed according to the definition of each center. Details regarding intensive care support were not described; hence, further stratification was not possible; this could have overestimated the surge capacity. Fourth, the overlap of reported cases from the same centers may cause some bias; however, we believe that the large sample size and similarity of patients can minimize this effect. Fifth, only one study assessed the 28day mortality and no studies reported long term-outcomes after hospital discharge [31] .

Finally, owing to several aspects, including the temporal and geographic development of the pandemic, limited data from low-income countries are available; they would be essentially the report from Brazil and the international report from ISARIC that included developing and developed countries [2, 5, 6, 10, 14, 15, 20, [34] [35] [36] .

The present study does have several strengths. As far as we are aware, this is first systematic review describing the interventions used and main clinical outcomes of COVID-19 patients admitted to the ICU. It describes a large number of ICU patients (n=69,093) in 37 countries over 5 continents. The addition of reports from national registries, although not peer reviewed, adds relevant and insightful epidemiologic data.

Our main findings reflect a substantial use of ICU beds when a COVID-19 patient is hospitalized. It also shows that nearly half of ICU patients used mechanical ventilation (57%) [2, 3, 5, 6, [8] [9] [10] [15] [16] [17] 19, 21, 22, [26] [27] [28] [29] 31, 32, 33, 36] and had a high mortality (59%) [6, 21, 28, 31, 33, 36] . 

World Health Organization (2020) Coronavirus disease (COVID-19): situation report 111

ISARIC International Severe Acute Respiratory and emerging Infection Consorti Database

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease

Singapore Novel Coronavirus Outbreak Research T (2020) Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region

ICNARC report on COVID-19 in critical care ICNARC Case Mix Programme Database

ANZICS Australian and New Zealand Intensive Care Society (2020) COVID-19 Guidelines

Clinical features of patients infected with 2019 novel coronavirus in

Clinical features and treatment of COVID-19 patients in northeast Chongqing

Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses

ICU and ventilator mortality among critically ill adults with COVID-19. medRxiv:2020

Covid-19 in Critically Ill Patients in the Seattle Region -Case Series

Clinical progression of patients with COVID-19 in Shanghai

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

China Medical Treatment Expert Group for C (2020) Clinical Characteristics of Coronavirus Disease 2019 in China

Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series

Zanos TP (2020) Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in

Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan

Epidemiologic features and clinical findings of COVID-19-infected patients in Suzhou

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China. Preprints with The Lancet

Clinical Characteristics of Children with Coronavirus Disease

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Clinical characteristics of laboratory cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis. Travel medicine and infectious disease

Comparison of epidemiological and clinical features of patients with coronavirus disease (COVID-19) in Wuhan and outside Wuhan, China-Manuscript Draft

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory medicine

Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (nonepicenter): A Nationwide Analysis of China

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study

COVID-BioB Study Group. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) -United States

NICE -National Intensive Care Evaluation COVID-19 op de Nederlandse Intensive Cares; Patiëntkarakteristieken en uitkomsten vergeleken met pneumonie patiënten

Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry The Lancet

Risk factors for mortality in patients admitted to intensive care units with pneumonia

Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia

Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand

Sepsis Institute N (2017) The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study

Incidence and outcomes of acute lung injury

Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries

Mortality reduction in adult community-acquired pneumonia in the UK (2009-2014): results from the British Thoracic Society audit programme

The role of noninvasive positive pressure ventilation in community-acquired pneumonia

Beyond the guidelines for non-invasive ventilation in acute respiratory failure: implications for practice. The Lancet Respiratory medicine

Guidance for the role and use of non-invasive respiratory support in adult patients with coronavirus (confirmed or suspected)

Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome

Critically Ill patients with 2009 influenza A(H1N1) in Mexico

Critically ill patients with 2009 influenza A(H1N1) infection in Canada

The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks

WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research

Core Outcomes Set for Trials in People With Coronavirus Disease

Arentz et al [10] Only ICU patients March 19, 2020 Evergreen